This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Simulating BRAFV600E-MEK-ERK signalling dynamics in response to vertical inhibition treatment strategies
npj Systems Biology and Applications Open Access 15 May 2024
Access options
References
Original article
Hargrave, D. R. et al. Phase II trial of dabrafenib plus trametinib in relapsed/refractory BRAF V600-mutant pediatric high-grade glioma. J. Clin. Oncol. https://doi.org/10.1200/JCO.23.00558 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Romero, D. Dabrafenib–trametinib is effective in paediatric high-grade glioma. Nat Rev Clin Oncol 20, 734 (2023). https://doi.org/10.1038/s41571-023-00820-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-023-00820-8
This article is cited by
-
Simulating BRAFV600E-MEK-ERK signalling dynamics in response to vertical inhibition treatment strategies
npj Systems Biology and Applications (2024)